Drug
Abt 288
Abt 288: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABT-288 NCT01018875 | Phase 2 | Alzheimer's Disease |
Latest
No recent events.
Follow Abt 288 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.